FDA Gives Approval To Knockoff Version Of Johnson & Johnson Remicade Drug

The U.S. Food and Drug Administration has approved Johnson & Johnson's Remicade biosimilar, Inflectra. Now, doctors may prescribe this infliximab drug to patients.